Events

Provepharm Inc. Issues Voluntary Nationwide Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter

Company Contact: Name: Provepharm Inc. Phone Number: 610-601-8600

FOR IMMEDIATE RELEASE - January 24, 2025 - Collegeville, Pennsylvania, Provepharm Inc.

Provepharm receives FDA approval for BLUDIGO™ (indigotindisulfonate sodium, USP) Injection

Marseille, France - Collegeville, PA 

 

BLUDIGOTM  is the first and only indigotindisulfonate sodium injection, USP, drug product approved by the FDA.

 

Event

Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Winter Meeting

Event

2024 Society of Gynecologic Oncology's (SGO) Annual Meeting on Women's Cancer

See you in San Diego! 

Event

88th Annual Meeting of the Southeastern Section of the AUA

Event

Society of Gynecological Surgeons (SGS) 50th Annual Scientific Meeting

See you in Orlando! 

Event

Health Connect Partners (HCP) Spring Hospital Pharmacy Conference

See you in Dallas! 

Vous allez quitter le site institutionnel de Provepharm. Si vous continuez, vous accèderez au site web de notre filiale américaine dont les informations ne s'appliquent pas nécessairement en France.